MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 266 filers reported holding MIRATI THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1,033 | -99.1% | 115,054 | +528.7% | 0.11% | +1666.7% |
Q2 2022 | $120,000 | +18.8% | 18,300 | -33.5% | 0.01% | +20.0% |
Q1 2021 | $101,000 | -73.2% | 27,500 | -83.8% | 0.01% | -54.5% |
Q4 2020 | $377,000 | +73.7% | 169,700 | +238.7% | 0.01% | -8.3% |
Q2 2020 | $217,000 | -28.6% | 50,100 | -61.8% | 0.01% | -42.9% |
Q1 2020 | $304,000 | -93.5% | 131,000 | +159.1% | 0.02% | -91.8% |
Q4 2019 | $4,690,000 | +710.0% | 50,552 | -70.6% | 0.26% | +446.8% |
Q3 2019 | $579,000 | -45.1% | 171,700 | -27.3% | 0.05% | -42.0% |
Q2 2019 | $1,055,000 | -4.3% | 236,200 | +331.4% | 0.08% | -17.3% |
Q1 2019 | $1,102,000 | – | 54,751 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |